Skip to main content
Journal of Bacteriology logoLink to Journal of Bacteriology
. 1998 Feb;180(3):732–736. doi: 10.1128/jb.180.3.732-736.1998

Modulation of Escherichia coli Adenylyl Cyclase Activity by Catalytic-Site Mutants of Protein IIAGlc of the Phosphoenolpyruvate:Sugar Phosphotransferase System

Prasad Reddy 1,*, Madhavi Kamireddi 1
PMCID: PMC106945  PMID: 9457881

Abstract

It is demonstrated here that in Escherichia coli, the phosphorylated form of the glucose-specific phosphocarrier protein IIAGlc of the phosphoenolpyruvate:sugar phosphotransferase system is an activator of adenylyl cyclase and that unphosphorylated IIAGlc has no effect on the basal activity of adenylyl cyclase. To elucidate the specific role of IIAGlc phosphorylation in the regulation of adenylyl cyclase activity, both the phosphorylatable histidine (H90) and the interactive histidine (H75) of IIAGlc were mutated by site-directed mutagenesis to glutamine and glutamate. Wild-type IIAGlc and the H75Q mutant, in which the histidine in position 75 has been replaced by glutamine, were phosphorylated by the phosphohistidine-containing phosphocarrier protein (HPr∼P) and were equally potent activators of adenylyl cyclase. Neither the H90Q nor the H90E mutant of IIAGlc was phosphorylated by HPr∼P, and both failed to activate adenylyl cyclase. Furthermore, replacement of H75 by glutamate inhibited the appearance of a steady-state level of phosphorylation of H90 of this mutant protein by HPr∼P, yet the H75E mutant of IIAGlc was a partial activator of adenylyl cyclase. The H75E H90A double mutant, which cannot be phosphorylated, did not activate adenylyl cyclase. This suggests that the H75E mutant was transiently phosphorylated by HPr∼P but the steady-state level of the phosphorylated form of the mutant protein was decreased due to the repulsive forces of the negatively charged glutamate at position 75 in the catalytic pocket. These results are discussed in the context of the proximity of H75 and H90 in the IIAGlc structure and the disposition of the negative charge in the modeled glutamate mutants.


Adenylyl cyclase catalyzes the synthesis of cyclic AMP (cAMP), which is of central importance in signal transduction, metabolism, and other cellular processes in both eukaryotes and prokaryotes. cAMP levels in the cell are primarily regulated by the modulation of adenylyl cyclase activity. Catabolic-enzyme synthesis in Escherichia coli is regulated by the cellular concentration of cAMP. Despite the vast literature on catabolite repression and the glucose effect that has accumulated over the past couple of decades (12, 14, 29), the precise molecular mechanism for glucose inhibition of cAMP synthesis in E. coli remains unclear. Adenylyl cyclase and the phosphoenolpyruvate (PEP):sugar phosphotransferase system (PTS) proteins have been implicated in catabolite repression. Energized by PEP and successively mediated by the PTS proteins, enzyme I, HPr, and enzyme(s) IIABC (25), PTS sugars are translocated into the cell as sugar phosphates. This results in the conversion of the PTS proteins from a phosphorylated state to a dephosphorylated state. Inhibition of adenylyl cyclase activity by the PTS sugars has long been known to be due to this event (15). Although genetic evidence suggests that the PTS-catalyzed phosphorylation of IIAGlc is involved in the activation of adenylyl cyclase (5, 24), no direct biochemical evidence is yet available to support this model. E. coli IIAGlc has two histidines, H75 and H90, in close proximity in the catalytic site (30). Histidine 90 is the target for phosphorylation by the phosphohistidine-containing phosphocarrier protein (HPr∼P) (4). Histidine 75 is conserved throughout the known proteins IIAGlc of bacterial systems (17). Histidine 75 is required for phosphorylated protein IIAGlc (IIAGlc∼P) to act as a phosphate donor to protein IIBCGlc and glucose (18). Based on these biochemical properties and the atomic structures of the IIAGlc family members (10, 30), IIAGlc catalytic-site mutants were created to define the role of IIAGlc phosphorylation in the regulation of adenylyl cyclase activity. The results presented here demonstrate that IIAGlc∼P is an activator of adenylyl cyclase while IIAGlc does not affect the basal enzyme activity.

DNA manipulations.

Digestion of DNA with restriction enzymes was performed according to the manufacturers’ recommendations. DNA fragments were separated by electrophoresis on SeaKem GTG agarose or NuSieve GTG agarose, and bands were excised and melted at 65°C in an equal volume of 10 mM Tris-HCl (pH 8.0)–1 mM EDTA. DNA fragments were purified by phenol extraction and ethanol precipitation. Ligation of DNA fragments was performed as described elsewhere (26). Strain C600 lambda lysogen was used as the host for transformation with the ligation mixtures and for isolation of recombinant plasmids. Competent cells of the E. coli strains used here were prepared by the Hanahan method (6).

Cloning of the crr gene into pACYC184 under the control of Ptet.

In order to express protein IIAGlc at levels as close to the physiological level as possible for studies on the regulation of adenylyl cyclase in the toluene-treated cells, the crr gene was cloned into low-copy-number plasmid pACYC184 (3) under the control of Ptet. The HindIII-SalI fragment of pACYC184 encompassing the tet promoter region and part of the structural gene was cloned into M13mp18. The three bases (5′TGT3′) 5′ to the tet initiation codon ATG were mutated to 5′CAT3′ by site-directed mutagenesis (28) to create the NdeI restriction recognition sequence. The HindIII-SalI fragment with the NdeI recognition sequence was amplified by PCR with the M13 forward and reverse primers. The amplified DNA was restricted with HindIII and SalI and cloned back into pACYC184 lacking the same fragment. The NdeI-SalI fragment containing the crr gene was cloned into the newly created NdeI site and the SalI site of pACYC184 such that crr expression would be under the control of Ptet.

Cloning of the crr gene into the pRE expression vector and purification of protein IIAGlc and the H75Q and H75E mutants.

The wild-type and mutant crr structural gene(s) was cloned as NdeI-SalI fragments into the respective sites in the pRE1 expression vector (20). A recombinant containing the wild-type crr gene was introduced into E. coli MZ1 (λcI857) (31). Expression and purification of wild-type protein IIAGlc were accomplished as described previously (21). The mutant proteins were similarly purified after expression in the crr deletion strain TP2865 transformed with plasmid pRK248 carrying the temperature-sensitive repressor (1).

Other methods.

The details of the adenylyl cyclase assay have been described elsewhere (7). Synthesis of [32P]PEP was accomplished as described elsewhere (22). Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (8), and labeled proteins were detected by autoradiography. Protein was estimated by the Lowry method (11). Oligonucleotides for mutagenesis were synthesized by the phosphoramidite method on an Applied Biosystems 380B DNA synthesizer. DNA sequence was determined, using Sequenase, by the dideoxy method of Sanger et al. (27) as modified by Biggin et al. (2).

Site-directed mutagenesis of histidines in protein IIAGlc.

The single-stranded DNA containing the crr gene in M13mp18 with an NdeI site at the initiation codon (21) was the starting material for site-directed mutagenesis of histidines 75 and 90 to glutamine and glutamate at each position. The three-dimensional structure of protein IIAGlc shows that the two histidine residues at positions 75 and 90 form the active site (Fig. 1A) (10, 30), H90 being the target for phosphorylation by HPr∼P. It was demonstrated that the H75Q IIAGlc mutant is phosphorylated by HPr∼P at H90 but fails to serve as a phosphoryl donor in the subsequent PTS phosphoryl transfer reaction; thus, it is permanently phosphorylated in the presence of PEP and the general energy coupling proteins enzyme I and HPr (18). In contrast, the H90Q mutant cannot be phosphorylated at all. These mutant proteins allow the examination of whether the phosphorylated or nonphosphorylated IIAGlc regulates adenylyl cyclase activity. In addition, the H75E and H90E mutant proteins were analyzed because the presence of a negative charge at the active site of this phosphocarrier protein may mimic the phosphorylated form of IIAGlc.

FIG. 1.

FIG. 1

The active sites of wild-type IIAGlc (A) and modeled H75E (B) and H90E (C) mutants. (A) The proximity of phosphorylatable H90 and the interactive H75 in the catalytic pocket of IIAGlc are shown. It is possible to replace H75 (B) and H90 (C) with glutamate without altering the rest of the structure and yet maintain electrostatic interactions between residues 75 and 90. The figure was produced based on the crystal structure of Bacillus subtilis IIAGlc (10), whose active site is very similar to that of the E. coli protein (30).

Regulation of adenylyl cyclase activity by the state of phosphorylation of IIAGlc.

Strain TP2865, which lacks the crr gene (9), was used to evaluate the ability of the wild-type and mutant IIAGlcs to regulate adenylyl cyclase activity. The strain was transformed with plasmid pDIA100, which overproduces adenylyl cyclase about 10-fold (23). Strain TP2865/pDIA100 was transformed either with pACYC184 as a control or pACYC184 carrying the wild-type crr gene or with one of the five mutants, H75Q, H75E, H90Q, H90E, and H75E H90A. The results in Table 1 show that the activity of adenylyl cyclase, in the presence of potassium phosphate, is strongly stimulated by complementation of the crr deletion strain with wild-type IIAGlc or the H75Q mutant. When the phosphorylation of the catalytic H90 residue is abolished by the H90Q or H90E mutation, adenylyl cyclase is not activated. This clearly demonstrates that the activation of adenylyl cyclase occurred by virtue of the phosphorylation at H90 of the wild-type and H75Q mutant of IIAGlc, because the nonphosphorylatable H90Q mutant failed to activate the enzyme. The H90E mutant also failed to activate adenylyl cyclase. However, the ability of H75E IIAGlc to activate adenylyl cyclase is intermediate compared to the abilities of the phosphorylated and dephosphorylated forms. This suggests either that the H90 moiety of the H75E IIAGlc mutant is phosphorylated by HPr∼P or that the H75E IIAGlc mutant, with the negatively charged glutamate in the catalytic pocket, may mimic the phosphorylated form of the wild-type protein. To address these possibilities, a H75E H90A IIAGlc double mutant was constructed in which phosphorylation at position 90 is prevented. Partial stimulation of adenylyl cyclase activity caused by H75E IIAGlc was reversed by the double mutant. This result suggests that H75E IIAGlc may be phosphorylated.

TABLE 1.

Modulation of adenylyl cyclase activity by the phosphorylation state of IIAGlca

Nature of crr allele Adenylyl cyclase activity (pmol of cAMP formed/min/mg of protein) with addition:
None K.Pi K.Pi + α-MG
crr deletion 58 ± 10 101 ± 4 59 ± 7
WT crr 109 ± 9 530 ± 60 90 ± 36
H75Q crr 108 ± 15 416 ± 42 118 ± 21
H75E crr 80 ± 3 218 ± 19 75 ± 6
H75E H90A crr 67 ± 16 121 ± 32 66 ± 9
H90Q crr 64 ± 12 100 ± 22 62 ± 8
H90E crr 60 ± 8 92 ± 15 61 ± 7
a

Cells were grown to mid-log phase at 37°C in Vogel and Bonner medium supplemented with 0.8% Difco nutrient broth, 0.5% glucose, 50 μg of ampicillin per ml, and 40 μg of chloramphenicol per ml. Cells from 50 ml of culture were centrifuged, washed with 25 mM Tris-HCl (pH 8.0), and suspended in 1 ml of Tris buffer. Toluenized cells were assayed for adenylyl cyclase at 30°C as described elsewhere (7). The standard incubation mixture of 0.25 ml contained 25 mM Bicine (pH 8.5), 20 mM MgCl2, 1 mM dithiothreitol, 1 mM [α-32P]ATP (20 to 30 cpm/pmol), 1 mM cAMP, 20 mM creatine phosphate, and 50 U of creatine phosphokinase. Dipotassium phosphate (K.Pi) (pH 8.5; 20 mM) and methyl-α-d-glucopyranoside (α-MG; 1 mM) were added as indicated. At 10 and 20 min, 100-μl aliquots were withdrawn and combined with 0.2 ml of 1 N perchloric acid to terminate the reaction. The results are the averages of data from four experiments ± the standard deviations. WT, wild type. 

We attribute the level of activation of adenylyl cyclase by the IIAGlc mutants to the nature of the mutation because negligible differences in the amount of IIAGlc produced in the pRE1 vector were observed. The amounts of protein(s) produced in the pRE1 vector after 15 min, 30 min, 1 h, and 2 h of PL induction in E. coli MZ1 were quantitated by gel scanning (data not shown). The amounts of protein(s) IIAGlc produced at each time point were equal, and all of the protein(s) IIAGlc was stable and soluble. Although the protein(s) IIAGlc produced from the pACYC184 vector was not quantitated by gel scanning because of the low level of expression, it is assumed that similar amounts of protein(s) IIAGlc were produced and that the level of activation of adenylyl cyclase by the protein(s) IIAGlc was due to the nature of the mutation rather than any differences in the amount of protein(s) IIAGlc produced.

In vitro phosphorylation of IIAGlc.

It is interesting to note the major difference between the phosphorylation patterns of the protein IIAGlc H75Q and H75E mutants (Fig. 2). While the glutamine mutant is phosphorylated by HPr∼P (lane 3), the glutamate mutant does not appear to be phosphorylated by HPr∼P (lane 4). The twofold activation of adenylyl cyclase by H75E IIAGlc may be reconciled by the facts that H75 and H90 in the catalytic pocket are proximal and that the negatively charged glutamate in protein IIAGlc H75E may function like phosphorylated H90 (Fig. 1B). Another plausible explanation for the activation of adenylyl cyclase by the protein IIAGlc H75E mutant is that this mutant gets transiently phosphorylated at H90, resulting in partial activation of adenylyl cyclase, but is rapidly dephosphorylated by the repulsive forces of the adjacent negatively charged glutamate residue such that the mutant is not observed in a steady-state phosphorylated form (Fig. 2, lane 4). A twofold activation of adenylyl cyclase by the H75E mutant and the reversal of this activation by the H75E H90A double mutant favor the argument that a transient phosphorylation of H90 of the H75E mutant may occur. The inability of H90E IIAGlc to activate adenylyl cyclase is not readily understood. Perhaps the carboxyl group of glutamate in the H90E mutant is buried compared to the phosphate group of H90 of the wild-type protein (Fig. 1C).

FIG. 2.

FIG. 2

Phosphoacceptor ability of wild-type protein IIAGlc and mutants H75Q and H75E. The phosphorylation reaction mixture contained 50 mM Tris-HCl (pH 8.0), 10 mM MgCl2, 1 mM dithiothreitol, 2 mM [32P]phosphoenolpyruvate, 3 μg of enzyme I, 6 μg of HPr, and 2 μg of IIAGlc as indicated. Lanes: 1, no IIAGlc; 2, wild-type IIAGlc; 3, H75Q IIAGlc; 4, H75E IIAGlc. Reaction mixtures were incubated at 37°C for 15 min, and proteins were separated on a sodium dodecyl sulfate–15% polyacrylamide gel. The 32P-labeled proteins were detected by autoradiography.

Relationship between adenylyl cyclase activation and phosphate pools.

There is substantial evidence that the activation of adenylyl cyclase by potassium phosphate is mediated through the PTS proteins (16). Furthermore, there is a clear relationship between the stimulation of adenylyl cyclase by potassium phosphate and the inhibition of adenylyl cyclase by glucose. Glucose has no effect on adenylyl cyclase basal activity. Only when the basal activity is stimulated by potassium phosphate is inhibition of adenylyl cyclase activity by glucose observed. As expected, glucose or methyl-α-d-glucopyranoside inhibited adenylyl cyclase activity in the strain transformed with the plasmid containing wild-type crr (Table 1). Surprisingly, a very similar result was observed with the H75Q mutant: it has been clearly demonstrated that this mutant cannot be dephosphorylated by methyl-α-d-glucopyranoside when purified PTS proteins are used (18). It is conceivable that in an intact cell, glucose or methyl-α-d-glucopyranoside may be vectorially phosphorylated, albeit at a slow rate, by the mannose pathway. Indeed, the efficient fermentation of glucose as well as mannose by the H75Q mutant (data not shown) is consistent with this interpretation. Thus, in an intact cell with the H75Q mutation, dephosphorylation of HPr can occur, and it in turn can be phosphorylated in the reversible reaction by the phospho-H75Q mutant. Such a turnaround dephosphorylation of the H75Q mutant would result in the deactivation of adenylyl cyclase.

It was shown that addition of glucose to starved Streptococcus lactis cells causes a rapid metabolism of and an instantaneous decrease in PEP and inorganic phosphate (Pi) pools from about 40 to 5 mM (13). Since the maximum activation of adenylyl cyclase occurs at 20 mM potassium phosphate, at least one pathway for deactivation of adenylyl cyclase by glucose was suggested to be by decreased cellular Pi pools (16). However, adenylyl cyclase assays were performed in vitro with toluene-treated cells equilibrated with 20 mM potassium phosphate, and addition of 1 mM glucose is not expected to cause any appreciable change in the Pi concentration. Moreover, the pattern of deactivation of adenylyl cyclase with glucose (data not shown) and a nonmetabolizable analog, methyl-α-d-glucopyranoside, are indistinguishable. Beyond the phosphorylation of methyl-α-d-glucopyranoside at the expense of PEP, no further metabolism takes place to account for the decreased Pi concentration. In fact, methyl-α-d-glucopyranoside in nanomolar concentrations has been shown to lower cAMP levels in intact cells of E. coli and Salmonella typhimurium (5). It appears that the minimum requirements for the high-activity form of adenylyl cyclase are a high Pi concentration and phosphorylated IIAGlc.

Speculation on the interaction of adenylyl cyclase with protein IIAGlc.

The crystal structure of protein IIAGlc suggests that there may be no gross conformational change in the protein upon phosphorylation (10, 30). Thus, we suggest that the acquisition of a negative charge at H90∼P is responsible for the interaction with adenylyl cyclase. Protein IIAGlc∼P and adenylyl cyclase may form a stable complex through charge interactions. Protein IIAGlc∼P is a positive effector and protein IIAGlc is a negative effector of different enzymes. This concerted role of phosphorylated and dephosphorylated protein IIAGlc has been demonstrated in the transport and catabolism of non-PTS sugars like lactose, glycerol, and maltose. While protein IIAGlc acts as a negative effector of the transport systems of these non-PTS sugars by binding to the sugar permeases, protein IIAGlc∼P dissociates from the sugar permeases and does not interfere with the transport. Protein IIAGlc∼P is a positive effector of adenylyl cyclase and thereby increases levels of cAMP, which is required for the transcription of the catabolic operons of lactose, glycerol, and maltose should the cells encounter these sugars.

All the models put forward for the regulation of adenylyl cyclase have been from studies using intact cells (5, 9, 24), toluenized cells (7), or crude extracts (19). Although it is trivial to obtain pure adenylyl cyclase from an overproducing E. coli strain (20), the impediment to pinpointing which of the PTS components is responsible for the regulation of adenylyl cyclase activity by the in vitro reconstitution and/or protein-protein interaction has been the failure to obtain the pure enzyme in a regulatable form. It is conceivable that an unidentified factor in the regulation of adenylyl cyclase escaped our search up to now.

Acknowledgments

We thank Antoine Danchin for his generosity in providing the crr deletion strain TP2865 and the cya plasmid pDIA100. Strains MZ1 and C600 lambda lysogen were a gift from D. Court of the National Cancer Institute, Frederick, Maryland. We are grateful to Osnat Herzberg for the molecular modeling of IIAGlc. We thank Keith McKenney and Jonathan Reizer for their valuable comments on the manuscript. We are grateful to Joel Hoskins for his help in the synthesis of oligonucleotides.

REFERENCES

  • 1.Bernard H-U, Helinski D R. Use of the λ phage promoter PL to promote gene expression in hybrid plasmid cloning vehicles. Methods Enzymol. 1979;68:482–492. doi: 10.1016/0076-6879(79)68037-0. [DOI] [PubMed] [Google Scholar]
  • 2.Biggin M D, Gibson T J, Hong G F. Buffer gradient gels and 35S label as an aid to rapid DNA sequence determination. Proc Natl Acad Sci USA. 1983;80:3963–3965. doi: 10.1073/pnas.80.13.3963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Chang A C Y, Cohen S N. Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid. J Bacteriol. 1978;134:1141–1156. doi: 10.1128/jb.134.3.1141-1156.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Dorschug M, Frank R, Kalbitzer H R, Hengstenberg W, Deutscher J. Phosphoenolpyruvate-dependent phosphorylation site in enzyme IIIglc of the Escherichia coli phosphotransferase system. Eur J Biochem. 1984;144:113–119. doi: 10.1111/j.1432-1033.1984.tb08438.x. [DOI] [PubMed] [Google Scholar]
  • 5.Feucht B U, Saier M H., Jr Fine control of adenylate cyclase by the phosphoenolpyruvate:sugar phosphotransferase systems in Escherichia coli and Salmonella typhimurium. J Bacteriol. 1980;141:603–610. doi: 10.1128/jb.141.2.603-610.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Hanahan D. Studies on transformation of Escherichia coli with plasmids. J Mol Biol. 1983;166:557–580. doi: 10.1016/s0022-2836(83)80284-8. [DOI] [PubMed] [Google Scholar]
  • 7.Harwood J P, Peterkofsky A. Glucose-sensitive adenylate cyclase in toluene-treated cells of Escherichia coli B. J Biol Chem. 1975;250:4656–4662. [PubMed] [Google Scholar]
  • 8.Laemmli U K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 1970;227:680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  • 9.Levy S, Zeng G-Q, Danchin A. Cyclic AMP synthesis in Escherichia coli strains bearing known deletions in the pts phosphotransferase operon. Gene. 1990;86:27–33. doi: 10.1016/0378-1119(90)90110-d. [DOI] [PubMed] [Google Scholar]
  • 10.Liao D-I, Kapadia G, Reddy P, Saier M H, Jr, Reizer J, Herzberg O. Structure of the IIA domain of the glucose permease of Bacillus subtilis at 2.2-Å resolution. Biochemistry. 1991;30:9583–9594. doi: 10.1021/bi00104a004. [DOI] [PubMed] [Google Scholar]
  • 11.Lowry O H, Rosebrough N J, Farr A L, Randall R J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–275. [PubMed] [Google Scholar]
  • 12.Magasanik B. Glucose effects: inducer exclusion and repression. In: Beckwith J R, Zipser D, editors. The lactose operon. Cold Spring Harbor, N.Y: Cold Spring Harbor Laboratory; 1970. pp. 189–219. [Google Scholar]
  • 13.Mason P W, Carbone D P, Cushman R A, Waggoner A S. The importance of inorganic phosphate in regulation of energy metabolism of Streptococcus lactis. J Biol Chem. 1981;256:1861–1866. [PubMed] [Google Scholar]
  • 14.Pastan I, Perlman R L. Repression of β-galactosidase synthesis by glucose in phosphotransferase mutants of Escherichia coli. Repression in the absence of glucose phosphorylation. J Biol Chem. 1969;244:5836–5842. [PubMed] [Google Scholar]
  • 15.Peterkofsky A. Regulation of Escherichia coli adenylate cyclase by phosphorylation-dephosphorylation. Trends Biochem Sci. 1977;2:12–14. [Google Scholar]
  • 16.Peterkofsky A. Redistribution of phosphate pools and the regulation of Escherichia coli adenylate cyclase activity. Arch Biochem Biophys. 1988;265:227–233. doi: 10.1016/0003-9861(88)90122-1. [DOI] [PubMed] [Google Scholar]
  • 17.Poolman B, Royer T J, Mainzer S E, Schmidt B F. Lactose transport system of Streptococcus thermophilus: a hybrid protein with homology to the melibiose carrier and enzyme III of phosphoenolpyruvate-dependent phosphotransferase systems. J Bacteriol. 1989;171:244–253. doi: 10.1128/jb.171.1.244-253.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Presper K A, Wong C-Y, Liu L, Meadow N D, Roseman S. Site-directed mutagenesis of the phosphocarrier protein, IIIGlc, a major signal transducing protein in Escherichia coli. Proc Natl Acad Sci USA. 1989;86:4052–4055. doi: 10.1073/pnas.86.11.4052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Reddy P, Meadow N, Roseman S, Peterkofsky A. Reconstitution of regulatory properties of adenylate cyclase in Escherichia coli extracts. Proc Natl Acad Sci USA. 1985;82:8300–8304. doi: 10.1073/pnas.82.24.8300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Reddy P, Peterkofsky A, McKenney K. Hyperexpression and purification of Escherichia coli adenylate cyclase using a vector designed for expression of lethal gene products. Nucleic Acids Res. 1989;17:10473–10488. doi: 10.1093/nar/17.24.10473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Reddy P, Fredd-Kuldell N, Liberman E, Peterkofsky A. Overproduction and rapid purification of the phosphoenolpyruvate:sugar phosphotransferase system proteins enzyme I, HPr, and protein IIIGlc of Escherichia coli. Protein Expr Purif. 1991;2:179–187. doi: 10.1016/1046-5928(91)90069-u. [DOI] [PubMed] [Google Scholar]
  • 22.Roossien F F, Brink J, Robillard G T. A simple procedure for the synthesis of [32P]phosphoenolpyruvate via the pyruvate kinase exchange reaction at equilibrium. Biochim Biophys Acta. 1983;760:185–187. doi: 10.1016/0304-4165(83)90141-1. [DOI] [PubMed] [Google Scholar]
  • 23.Roy A, Danchin A. The cya locus of Escherichia coli K12: organization and gene products. Mol Gen Genet. 1982;188:465–471. doi: 10.1007/BF00330050. [DOI] [PubMed] [Google Scholar]
  • 24.Saier M H, Jr, Feucht B U. Coordinate regulation of adenylate cyclase and carbohydrate permeases by the phosphoenolpyruvate:sugar phosphotransferase system in Salmonella typhimurium. J Biol Chem. 1975;250:7078–7080. [PubMed] [Google Scholar]
  • 25.Saier M H, Jr, Reizer J. Proposed uniform nomenclature for the proteins and protein domains of the bacterial phosphoenolpyruvate:sugar phosphotransferase system. J Bacteriol. 1992;174:1433–1438. doi: 10.1128/jb.174.5.1433-1438.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Sambrook J, Fritsch E F, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, N.Y: Cold Spring Harbor Laboratory; 1989. [Google Scholar]
  • 27.Sanger F, Nicklen S, Coulson A R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA. 1977;74:5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Sayers J R, Schmidt W, Eckstein F. 5′-3′ exonucleases in phosphorothioate-based oligonucleotide-directed mutagenesis. Nucleic Acids Res. 1988;16:791–802. doi: 10.1093/nar/16.3.791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Ullmann A. Catabolite repression 1985. Biochimie. 1985;67:29–34. doi: 10.1016/s0300-9084(85)80227-3. [DOI] [PubMed] [Google Scholar]
  • 30.Worthylake D, Meadow N D, Roseman S, Liao D-I, Herzberg O, Remington J S. Three-dimensional structure of the Escherichia coli phosphocarrier protein IIIglc. Proc Natl Acad Sci USA. 1991;88:10382–10386. doi: 10.1073/pnas.88.23.10382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Zuber M, Patterson T A, Court D L. Analysis of nutR, a site required for transcription antitermination in phage lambda. Proc Natl Acad Sci USA. 1987;84:4514–4518. doi: 10.1073/pnas.84.13.4514. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES